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Topotecan (TOP), a water-soluble derivative of camptothecin, is a potent antitumor agent that is receiving growing 
attention for the treatment of several types of cancer. However, one of the major constraints in the clinical use of this 
drug is its inactivation at the physiological pH of 7.4. Mesoporous silica nanoparticles (MSNs) constitute promising 
nanocarriers to circumvent this issue. Herein TOP has been encapsulated into MSNs and the nanosystem has been 
provided of selectivity towards tumor cells, which permits releasing the active form of the molecule at the acidic cell 
compartments (endo/lysosomes; pH  5.5) following nanoparticles internalization. For this purpose, MSNs have been 
coated with a multifunctional gelatin shell that: i) protects TOP from hydrolysis and prevents its premature release; ii) acts 
as a pH-sensitive layer; and iii) provides multiple anchoring points for the grafting of targeting ligands, such as folic acid 
(FA), for selective internalization in tumor cells. In vitro tests demonstrate that cancer cells, which overexpress membrane 
cell surface markers with affinity towards FA, internalize higher percentage of nanoparticles than healthy cells, which do 
not overexpress such markers. Moreover, the nanosystems are efficient at killing tumor cells, whereas they do not 
decrease viability of normal cells. Contrarily, free TOP failed to kill both cell lines, which can be ascribed to the inactivation 
of the drug. This novel nanodevice constitutes a step forward toward the design of novel weapons to fight against cancer. 
1. Introduction 
Topotecan (TOP), a synthetic water-soluble derivative of 
camptothecin, is a DNA topoisomerase I inhibitor that has 
gained broad acceptance in clinical use as antineoplastic 
agent.
1,2
 It has been approved by U.S. Food and Drug 
Administration (FDA) for treating several types of cancer, such 
as ovarian, cervical and small cell lung.
3
 Its antitumor activity is 
also being investigated, either alone or in combination with 
other anticancer drugs, in neuroblastoma, Ewing’s sarcoma, 
etc. One of the major limitations of this drug is that under 
neutral or alkaline conditions, the TOP lactone moiety 
undergoes a rapid and reversible pH-dependent conversion to 
a carboxylated open-ring form, which lacks of antitumor 
activity. On the contrary, in acidic conditions TOP is stable and 
preserves the active lactone form.
4,5
 Thus, clinical trials 
revealed that the plasma TOP lactone concentration dropped 
rapidly with a harmonic mean half-life of 3.4 h, being lactone 
hydrolysis and renal excretion the principal routes of 
elimination.
6
 This requires the administration of high drug 
doses, which provokes unwanted side-effects in the patient.
7
  
This issue could be circumvented by using nanocarriers that 
were selectively internalized by cancer cells and protected TOP 
from hydrolysis until the active drug was delivered inside the 
acidic pH of endosomes (pH = 5.5–6.0) or lysosomes (pH = 4.5–
5.0).
8
 Nonetheless, the selective TOP delivery to cancer cells by 
targeted pH-responsive nanocarriers still remains a major 
challenge. Albeit diverse organic
9-14 
and inorganic
15-20 
nanocarriers have been proposed as TOP nanotherapeutics, 
none of them have fulfill the above-mentioned conditions. 
Among inorganic nanocarriers, mesoporous silica 
nanoparticles (MSNs) own unique properties such as tunable 
size, shape and porosity, high loading capacity, robustness and 
easy functionalization, which permit loading diverse antitumor 
agents.
21,22
 Moreover, they exhibit low cytotoxycity
23
 and good 
hemocompatibility,
24 
which is mandatory for intravenous 
administration. All these reasons have made MSNs noteworthy 
of interest by the scientific community and many targeted 
stimuli responsive drug delivery systems for antitumor therapy 
have been reported.
25-37
 However, to the best of our 
knowledge, there are only two pH-responsive TOP MSNs-
based systems.
18,19
 One of them consists in coordination 
polymer coated MSNs for the pH-triggered TOP release.
18
 The 
other one involves sophisticated multifunctional enveloped 
MSNs for subcellular co-delivery of TOP and a therapeutic 
peptide.
19
 Nonetheless, none of them have been designed to 
be selectively internalized by cancer cells. 
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Scheme 1. Schematic illustration of the tumor-targeted TOP nanosystem 
consisting of MSNs encapsulating TOP, coated with a gelatin shell and decorated 
with folic acid (FA) as targeting ligand. FSM stands for surface markers with 
affinity towards FA, which are usually overexpressed in the membrane of certain 
tumor cells. 
Herein we have designed and developed a selective and cost-
effective TOP nanodevice able to selectively address cancer 
cells and once internalized release the active form of the drug 
in the pH-acidic intracellular compartments (Scheme 1). For 
this purpose, MCM-41-type MSNs were chosen as TOP 
nanocarriers. Gelatine coating was chosen as pH-sensitive shell 
to block the mesopores and prevent premature release, as 
well as facilitating the grafting of targeting agents. Folic acid 
(FA) was grafted onto gelatine to provide the system of 
selective targeting capability to tumour cells, either since its 
receptor (FA-R)
38-40
 or folate binding proteins (FBP)
41
 are 
frequently overexpressed on the surface of human cancer 
cells. The pH-responsive TOP release performance of the 
nanosystems was evaluated “in vial”, demonstrating that in 
acidic conditions (pH 5.3) drug release was faster than in 
physiological conditions of (pH 7.4). Then the capacity of these 
nanodevices to selectively kill human prostate cancer cells 
(LNCaP), overexpressing folate binding proteins (FBP), 
compared to healthy preosteoblast cells (MC3T3-E1), non-
overexpressing such membrane proteins, was in vitro 
evaluated. The results indicated the selective internalization of 
the nanosystems into tumour cells and the efficient pH-
dependent TOP release. This novel nanosystem is envisioned 
as a promising candidate to be incorporated in the existing 
library of weapons for cancer treatment. 
2. Experimental Section 
Reactants  
The following reagents were purchased from Sigma-Aldrich 
Inc. (St. Louis, USA): tetraethylorthosilicate (TEOS, 98%), n-
cetyltrimethylammonium bromide (CTAB, ≥99 %); sodium 
hydroxide (NaOH, ≥98 %), ammonium nitrate (NH4NO3, ≥98 %), 
sodium carbonate (Na2CO3, ≥99,5 %); fluorescein 5(6)-
isothiocyanate (FITC, ≥98 %), (3-aminopropyl)triethoxysilane 
(APTES, ≥98 %), gelatin Ph Eur, glutaraldehyde grade I 50 wt.% 
solution in water, folic acid (FA, >97%), N,N’-
dicyclohexylcarbodiimide (DCC, 99%), N-hydroxysuccinimide 
(NHS, 98 %), phosphate-buffered saline (PBS, 10x), 
hydrochloric acid (HCl, 37%), and topotecan hydrochloride 
hydrate (TOP, ≥98 %). All other chemicals were purchase in 
Panreac Química SLU (Castellar del Valles, Barcelona, Spain) 
inc: absolute ethanol (EtOH), acetone, dimethyl sulfoxide 
(DMSO), etc., were of the best quality commercially available. 
All reagents were used as received without further 
purification. Ultrapure deionized water with resistivity of 18.2 
M was obtained using a Millipore Milli-Q plus system 
(Millipore S.A.S., Molsheim, France). 
 
Characterization Techniques  
The powder X-Ray Diffraction (XRD) experiments were 
performed in a Philips X’Pert diffractometer equipped with Cu 
Kα radiation (wavelength 1.5406 Å) (Philips Electronics NV, 
Eindhoven, Netherlands). XRD patterns were collected in the 
2 range between 0.6° and 8° with a step size of 0.02° and 
counting time of 5 s per step. Thermogravimetric (TG 
measurements were performed in a Perkin Elmer Pyris 
Diamond TG/DTA analyser (Perkin Elmer, California, USA), by 
placing 10 mg of sample in an aluminium crucible and applying 
5 ºC/min heating ramps, from room temperature to 600 ºC. 
Fourier transform infrared spectroscopy (FTIR) was carried out 
in a Nicolet (Thermo Fisher Scientific) Nexus equipped with a 
Goldengate attenuated total reflectance device (Thermo 
Electron Scientific Instruments LLC, Madison, WI USA). Surface 
morphology was analysed by High Resolution Transmission 
Electron Microscopy (HRTEM) with a JEOL JEM 3000F 
instrument operated at 300 kV, equipped with a CCD camera 
(JEOL Ltd., Tokyo, Japan). Sample preparation was performed 
by dispersing (aided by an ultrasounds bath) 1 mg of sample in 
1 mL of distilled water, and subsequently depositing one drop 
of the suspension onto carbon-coated copper grids. A solution 
of 1% of PTA (pH 7.0) was employed as staining agent in order 
to visualize the organic coating around MSNs.  
The hydrodynamic size of nanoparticles by dynamic light 
scattering (DLS) and zeta (-potential were measured in a 
Zetasizer Nano ZS (Malvern Instruments Ltd., United Kingdom) 
equipped with a 633 nm “red” laser. For this purpose 10 mg of 
nanoparticles was added to 10 mL of water and the mixture 
was sonicated for 5 min to get a homogeneous suspension. In 
the case of -potential measurements the pH was adjusted by 
adding appropriated amounts of HCl 0.1 M or NaOH 0.1 M to 
the suspension under magnetic stirring. In both cases, 
measurements were recorded by placing ca. 1 mL of 
suspension (1mg/mL) in DTS1070 disposable folded capillary 
cells (Malvern). The textural properties of the materials were 
determined by N2 adsorption porosimetry by using a 
Micromeritics ASAP 2020 (Micromeritics Co., Norcross, USA). 
To perform the N2 measurements, ca. 30 mg of each sample 
was previously degassed under vacuum for 24 h at 40 ºC 
temperature. The surface area (SBET) was determined using the 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3  
Please do not adjust margins 
Please do not adjust margins 
Brunauer-Emmett-Teller (BET) method and the pore volume 
(VP) was estimated from the amount of N2 adsorbed at a 
relative pressure around 0.99. The pore size distribution 
between 0.5 and 40 nm was calculated from the desorption 
branch of the isotherm by means of the Barrett-Joyner-
Halenda (BJH) method. The mesopore size (Dp) was 
determined from the maximum of the pore size distribution 
curve. 
Synthesis of mesoporous silica nanoparticles (MSN). 
Bare MSNs, denoted as MSN, were synthesized by the 
modified Stöber method using TEOS as silica source in the 
presence of CTAB as structure directing agent. Thus, 1 g of 
CTAB, 480 mL of H2O and 3.5 mL of NaOH (2 M) were added to 
a 1L round-bottom flask. The mixture was heated to 80 ºC and 
magnetically stirred at 600 rpm. When the reaction mixture 
was stabilized at 80 ºC, 5 mL of TEOS were added dropwise at 
0.33 mL/min rate. The white suspension obtained was stirred 
during further 2h at 80 ºC. The reaction mixture was 
centrifuged and washed three times with water and ethanol. 
The surfactant was removed by ionic exchange by soaking 1 g 
of nanoparticles in 500 mL of a NH4NO3 solution (10 mg/mL) in 
ethanol (95%) at 80 ºC overnight under magnetic stirring. MSN 
were collected by centrifugation, washed three times with 
ethanol and dried under vacuum at 40 ºC.   
 
Capping of MSN with gelatin (MSNgel) 
Capping of MSN with gelatin was performed by adapting a 
method described elsewhere,
42
 affording MSNgel. Thus, 50 mg 
of MSN were suspended in 5 mL of a gelatin solution (10 
mg/mL in PBS 1× pH = 7.4) and left to react for 6 h at 50 ºC. 
Then, 25 mL of cold PBS 1× (4 ºC) were added. The mixture 
was gently shaken and then the supernatant was separated by 
centrifugation and the solid was washed twice with 25 mL of 
cold PBS. Subsequently, the sample was suspended in 25 mL of 
fresh cold PBS 1×, 75 L of a solution of glutaraldehyde (1%), 
as the crosslinking agent, was added and the mixture was 
allowed to react overnight in a refrigerator (4 ºC) under 
magnetic stirring. Crosslinking of gelatin with glutaraldehyde 
was carried out with the aim of preventing its premature 
dissolution in aqueous media.
43
 Finally, the mixture was 
centrifuged, washed twice with PBS 1× and dried under 
vacuum for 24 hours at room temperature. 
For cellular internalization and degradation studies fluorescein 
labeled MSNgel were synthesized. For this purpose, 
fluorescent gelatin was prepared using a protocol described 
elsewhere.
44
 Briefly, 2.4 g of gelatin and 6 mg FITC was 
dissolved in 25 mL Na2CO3 buffer (pH = 8.5). The solution was 
heated to 40 ºC under magnetic stirring. After 8 h of reaction 
in the darkness, the gelatin solution was transferred into a 
dialysis bag with Mw cutoff of 8000–14,000 Da and immersed 
in deionized water at 40 ºC to remove the free FITC. The 
dialysis was performed for 3 days and the water was changed 
4–6 times each day. Finally, the solution was poured into a 
culture dish and dried at 70 ºC to obtain the yellow-colored 
FITC-modified gelatin slices. Then, the synthesis of fluorescent 
MSNgel was carried out following the above mentioned 
methodology for MSNgel but using fluorescent gelatin during 
the process. 
 
Attachment of Folic Acid to MSNgel (MSN-FA)  
10 mg of MSNgel were placed in a vial and suspended in 2 mL 
of PBS 1× (pH = 7.4). Then, 250 L of an activated FA solution 
were added. The activated FA solution was prepared by adding 
10 mg of FA and 15 mg of DCC to 250 L of DMSO at 40ºC.  
The mixture was stirred for 1h, after that 10 mg of NHS were 
added and the reaction was allowed to stir for 2 more hours 
before being added to the MSNgel suspension. The activated 
FA and MSNgel were kept under magnetic stirring during 5 
hours at room temperature. Then, the resulting MSN-FA 
sample was collected by centrifugation and washed twice with 
4 mL of PBS 1× (pH = 7.4) and left to dry under vacuum at 25 
ºC. Finally, the synthesis of fluorescent MSN-FA, was carried 
out following the above mentioned methodology but grafting 
FA to fluorescein labeled MSNgel.  
 
TOP loading  
50 mg of MSN were placed in a dark glass vial and dried at 
80ºC overnight under vacuum. Then, 5 mL of an aqueous 
solution of TOP (3 mg/mL) were added to the vial and the 
suspension was stirred at room temperature for 48 h. Then, 
the excess TOP was removed by centrifugation and washed 
once in water. The amount of drug loaded in MSN was 
determined from the different between the fluorescence 
measurements of the initial and the recovered filtrate 
solutions. Gelatin capping and grafting of FA was then carried 
out by following the procedures previously described, 
affording MSN-FA(TOP). 
 
“In vial” TOP release assays  
To evaluate the pH-dependent TOP release behaviour of MSN-
FA “in vial” release experiments at two different pH values, i.e. 
7.4 and 5.3, were performed. For this purpose, two batches of 
6 mg of TOP-loaded MSN-FA were prepared. One of them was 
suspended in 1.5 mL of fresh PBS 10 mM (pH 7.4), and then 0.5 
mL of nanoparticles suspension were placed on a Transwell
®
 
permeable support with 0.4 µm of polycarbonate membrane 
(3 replicas were performed). The well was filled with 1.5 mL of 
PBS 10 mM (pH 7.4) and the suspension was kept under orbital 
stirring at 100 rpm and 37ºC during all the experiment. The 
second batch was submitted to the same procedure but using 
PBS 10 mM (pH 5.3) during the release assay. At every time 
point studied, the solution outside the Transwell insert was 
replaced with fresh medium and the amount of TOP released 
was determined by fluorescence spectrometry (λexc 400, λem 
530 nm) in a in a BioTek Spectrofluorimeter (BioTek 
Instruments GmbH, Germany) 
In an attempt of elucidating the mechanism that governs the 
changes induced in the gelatin coating by the variation in the 
pH (degradation or swelling), two additional experiments were 
carried out. The first one consisted in suspending fluorescent 
MSNgel, in PBS at two different pH values (pH 7.4 and pH 5.3) 
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and kept under magnetic stirring up to 48 h. At given times the 
medium was replaced by fresh one and the fluorescence of the 
supernatant was measured. The second one consisted in 
soaking MSNgel nanosystems into aqueous solutions at the 
two above mentioned pH values and monitoring the 
hydrodynamic size of nanoparticles vs. time by DLS 
measurements.  
 
Cell cultures  
Cell culture tests were performed using the well-characterized 
mouse osteoblastic cell line MC3T3-E1 (subclone 4, CRL-2593; 
ATCC, Mannassas, VA) and androgen-sensitive LNCaP cells, a 
human prostate cancer cell line (CRL-1740; ATCC, Mannassas, 
VA). The tested MSNs were placed into each well of 6- or 24-
well plates (Corning, CULTEK, Madrid, Spain) after cell seeding. 
MC3T3-E1 and LNCaP cells were then plated at a density of 
30,000 cells cm
2 
in 1 mL of -minimum essential medium or 
Dulbecco’s modified Eagle’s medium (DMEM, Sigma Chemical 
Company), respectively, containing 10% of heat-inactivated 
foetal bovine serum (FBS, ThermoFisher Scientific, Waltham, 
MA, USA) and 1% penicillin–streptomycin (BioWhittaker 
Europe, Verviers, Belgium) at 37 ºC in a humidified 
atmosphere of 5% CO2, and incubated for different times. 
Some wells contained no MSNs as controls. 
 
Cell viability  
Cell growth was analysed using the CellTiter 96_ AQueous 
Assay (Promega, Madison, WI, USA), a colorimetric method for 
determining the number of living cells in culture. Briefly, both 
type of cells were cultured as described above without 
(control) or with the tested materials for several times. At 24 
h, 40 µL of CellTiter 96_ AQueous One Solution Reagent 
(containing 3-(4,5-dimethythizol-2-yl)-5-(3-carboxymethoxy 
phenyl)-2-(4-sulfophe-nyl)-2H-tetrazolium salt (MTS) and an 
electron coupling reagent (phenazine ethosulfate) that allows 
its combination with MTS to form a stable solution) was added 
to each well and incubated for 4h. The absorbance at 490 nm 
was then measured in a Unicam UV-500 UV–visible 
spectrophotometer (Thermo Spectronic, Cambridge, UK). 
 
Confocal laser scanning microscopy (CLSM) 
Cellular uptake and internalization of the fluorescence MSNs 
were observable by CLSM. Cells were incubated with the MSNs 
(100 µg/mL) for 2 h. Each well was washed with cold PBS for 
three more times to get rid of the nanoparticles no 
internalized into the cells, and then fixed with 75% ethanol 
(kept at −20°C) for 10 min. After being suck the ethanol and 
washed three times with cold PBS, the nucleus of both types of 
cells were stained with DAPI for 5 min, respectively, and then 
washed three times with cold PBS. Cellular uptake of MSNs 
was recorded by confocal laser scanning microscopy (CLSM) 
(Leica TCS SP5, Leica Microsystems Co. Ltd., Solms, Germany) 
with an excitation wavelength at λ = 488 nm. The emission was 
detected by using a 610-nm long pass filter. 
 
Fluorescence microscopy 
Fluorescence microscopy was performed with an Evos FL Cell 
Imaging System (ThermoFisher Scientific) equipped with tree 
Led Lights Cubes (lEX (nm); lEM (nm)): DAPY (357/44; 447/60), 
GFP (470/22; 525/50), RFP (531/40; 593/40) from AMG 
(Advance Microscopy Group). 
 
Flow cytometry studies  
MC3T3-E1 and LNCaP cells were cultured in each well of a 6-
well plate. After 24h, the cells were incubated at different 
times in the absence or presence of the tested MSNs (100 
µg/mL). After 2 h, cells were washed twice with PBS and 
incubated at 37C with trypsin–EDTA solution for cell 
detachment. The reaction was stopped with culture medium 
after 5 min and cells were centrifuged at 1.000 rpm for 10 min 
and resuspended in fresh medium. Then, the surface 
fluorescence of the cells was quenched with trypan blue (0.4%) 
to confirm the presence of an intracellular, and therefore 
internalised, fluorescent signal. Flow cytometry measurements 
were performed at an excitation wavelength of 488 nm, green 
fluorescence was measured at 530 nm (FL1). The trigger was 
set for the green fluorescence channel (FL1). The conditions 
for the data acquisition and analysis were established using 
negative and positive controls with the CellQuest Program of 
Becton–Dickinson and these conditions were maintained 
during all the experiments. Each experiment was carried out 
three times and single representative experiments are 
displayed. For statistical significance, at least 10,000 cells were 
analysed in each sample in a FACScan machine (Becton, 
Dickinson and Company, USA) and the mean of the 
fluorescence emitted by these single cells was used. 
3. Results and Discussion 
3.1. Characterization of the nanosystems 
Mesoporous silica nanoparticles, MSN, were synthetized by a 
modification of the well-known Stöber method. MSN were 
coated with gelatine cross-linked with grutaraldehyde, 
affording MSN-gel and finally folic acid (FA) was grafted to the 
external surface of MSN-gel, leading to MSN-FA nanosystems. 
The successful gelatine coating onto MSN and subsequent 
grafting of FA was confirmed by using different 
characterization techniques. FTIR spectrum of MSN displays 
vibration bands in the 490-1090 cm
-1
 range characteristic of 
pure silica materials (Fig. 1).  
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Fig. 1. FTIR spectra of the different nanomaterials synthetized in this work. 
FTIR spectrum of MSNgel exhibit additional bands in the 1200-
3500 cm
-1
 region, with two main signals centred at 1632 and 
1524 cm
-1 
that can be respectively attributed to the C=O and 
N-H stretching bands of gelatin. The presence of an additional 
absorption band at ca. 1443 cm
-1
, which can be ascribed to 
aldimine stretching vibration, would provide further evidence 
of gelatine crosslinking with glutaraldehyde (Fig. 1). Finally 
FTIR spectrum of MSN-FA displays signals appearing in the 
3600-3000 cm
−1
 range assigned to hydroxyl (-OH) stretching 
and N-H stretching vibrations bands of FA. A slight 
displacement of the C=O stretching vibration (1624 cm
−1
) 
associated to an increase in the relative intensity of this band 
would account for a greater the number of amide bonds in this 
sample due to the reaction between carboxylic acid groups of  
FA and amine groups of gelatin. Finally, the signal appearing at 
1570 cm
−1 
can be assigned to the bending vibration mode of N-
H of FA, and the characteristic absorption peak of its phenyl 
ring appears at 1439 cm
−1
.  
 
Table 1. Main properties of nanosystems synthetized in this work (N=3).  
Material MSN MSNgel MSN-FA 
Organic matter (TG) (%) 7.5 ± 0.2 37.2 ± 0.7 58.0 ± 1.2 
SBET (m
2/g) 1116 ± 33 27 ± 1 19 ± 1 
VP (cm
3/g) 1.14 ± 0.03 0.14 ± 0.01 0.07 ± 0.01 
DP (nm) 3.0 ± 0.1 - - 
IEP < 3 ± 0.2 5.3 ± 0.5 4.6 ± 0.4 
Mean size (DLS) (nm) 190 ±5 220 ± 25 255 ±14 
 
Table 1 summarizes some of the most relevant features of the 
nanosystems synthetized in this work. The differences 
between TG measurements allowed determining the organic 
matter content incorporated in the nanosystems, being ca. 
29.7% the amount of gelatin present in MSNgel and ca. 20.8% 
the amount of FA in the final system, MSN-FA. 
Low-angle XRD pattern of pristine MSN displays four well 
resolved peaks that can be indexed as 100, 110, 200 and 210 
reflections of a well-ordered 2D-hexagonal structure with 
p6mm space group typical of MCM-41 (Fig. S1). However, XRD 
patters of MSNgel and MSN-FA only exhibit a weak signal that 
could be scarcely assigned to 100 reflection. In a first instance, 
this finding could point to a loss of mesostructural order due 
to the gelatine coating and FA grafting processes. Nonetheless, 
it has been widely demonstrated that it is difficult to detect 
alterations in the crystal structures solely from powder 
XRD.
45,46 
In fact, the disappearance of the signals in XRD 
patters of coated nanosystems may be also ascribed to the 
effective filling of the mesopore channels by the gelatin, as it 
has been previously reported for mesoporous materials 
functionalized by post-synthesis using great size molecules, 
such as high generation dendrimers.
47
 This would be in 
agreement with the results derived from N2 adsorption 
discussed below, where a decrease in the textural properties 
of nanosystems takes place due to the incorporation of organic 
content. Certainly, this affirmation is in agreement with 
HRTEM studies of the different nanosystems, whose 
corresponding Fast Fourier Transforms (FT) point to a well 
order 2D-hexagonal structure, vide infra.  
N2 adsorption-desorption isotherms are of type IV 
corresponding to mesoporous materials (Fig. S2). The 
appropriate treatment of the experimental data evidence the 
decrease in the textural parameters of samples once coated by 
gelatine and gelatine-FA, which allowed confirming the 
efficiency of the coating process.  The decrease in the surface 
area (SBET) from 1116 m
2
/g for MSN to 27 m
2
/g and 19 m
2
/g for 
MSNgel and MSN-FA, respectively. The exceptional decrease in 
surface area accessible to N2 in the gelatine-containing 
samples accounts for the successful coating of the MSN core, 
in agreement with TEM, vide infra. The pore volumes (VP) also 
experience a dramatically decrease, dropping from 1.14 cm
3
/g 
for MSN to 0.14 cm
3
/g and 0.07 cm
3
/g for MSNgel and MSN-
FA, respectively. The union of folic acid to gelatin (MSN-FA) 
produces a slight decrease in the surface area and pore 
volume still available in MSNgel. This may be ascribed to the 
large amount of FA anchored to the gelatin shell (ca. 20% 
according to TGA). Thus FA itself could be blocking some of the 
remaining porosity accessible to N2. Another fact to take into 
account is that the FA grafting is carried out in the presence of 
DCC and NHS. As it has been reported in the literature this 
mixture acts as gelatin cross-linker,
48 
which would explain a 
higher biopolymer crosslinking degree and therefore would 
lead to a decrease in the textural properties (SBET and VP) of 
the resulting nanosystem. 
Pore diameter (DP) was ca. 3.0 nm for MSN whereas it could 
not be determined in the case of MSNgel and MSN-FA 
samples. All these findings may account not only to the 
external covering of MSN by organic coatings but also the 
partial occupation of the mesoporous cavities organic matter, 
in agreement with XRD results.  
TEM images and their corresponding FT of samples confirm a 
honeycomb mesoporous arrangement typical of MCM-41 (Fig. 
2). The coating and FA grafting processes do not affect the 
mesostructural order of MSN. The morphology of the 
nanoparticles is neither influenced, showing spherical particles 
in all cases. Staining of samples with phosphotungstic acid 
(PTA) allowed observing the organic coatings as high contrast 
areas and the inorganic silica matrix as brighter zones in TEM 
images. The average diameter of the nanosystems estimated 
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from the 20 measurements was ca. 170 nm, 180 nm and 190 
nm for MSN, MSNgel and MSN-FA, respectively. Moreover, the 
average thickness of the organic shell determined from 20 
measurements was ca. 4 nm and 6 nm for MSNgel and MSN-
FA, respectively. 
 
Fig. 2. TEM images and their corresponding FT of the different nanosystems 
synthetized in this work. Samples were stained with 1% of phosphotungstic acid (PTA). 
To get information about the hydrodynamic size and surface 
charge of the nanosystems, dynamic light scattering (DLS) and 
-potential measurements were recorded in suspensions of 
these materials in water. The mean sizes determined by DLS in 
water were found to be 190 nm, 220 nm and 255 nm for MSN, 
MSNgel and MSN-FA samples, respectively (Fig. S3), which 
reasonably were slightly higher than those estimated from 
TEM images. This fact can be explained because DLS provides 
the hydrated hydrodynamic diameter whereas TEM shows the 
size in a dry state.
49
 As expected, these differences are more 
pronounced in MSNgel and MSN-FA because the presence of 
the hydrophilic polymeric coatings allows the formation of 
thicker hydration layers than in MSN.
50
   
The isoelectric point (IEP) of samples, which is tightly related 
with the zero-surface charge value (-potential = 0) of these 
particles (Table 1) were estimated by recording -potential vs 
pH plots (Fig. S4). The different profiles of the plots and IEP 
account for the successfully coating with gelatin and FA 
grafting. 
 
3.2. “In vial” pH-responsive TOP release performance 
TOP was loaded into MSN by soaking suspensions of 50 mg 
nanoparticles in 5 mL of a concentrated solution of TOP (3 
mg/mL) (for further details see Experimental Section). The 
amount of TOP loaded into MSN was found to be ca. 5% in 
weight. The successful drug loading was confirmed by the 
decrease in the VP measured by N2 adsorption (data not 
shown).   
With the aim of evaluating the performance of the complete 
nanosystem, MSN-FA, under physiological relevant conditions 
mimicking extracellular conditions (pH = 7.4) and those of 
endosomes or lysosomes (pH  5.5) TOP release assays were 
carried out “in vial”. Fig. 3 shows the TOP release profiles from 
MSN-FA after soaking the nanosystem into aqueous solutions 
at pH 7.4 and pH 5.3 during 48 hours. Release profiles can be 
adjusted to first-order kinetic model by introducing an 
empirical non-ideality factor () to give the equation:
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     (      )        (Eq. 1) 
with Y being the percentage of TOP released at time t, A the 
maximum amount of TOP released (in percentage), and k, the 
release rate constant. In this approach, the values for  are 
comprised between 1 for materials that obeys fist-order 
kinetics, and 0, for materials that release the loaded drug in 
the very initial time of test. The parameters of the kinetic 
fitting shown in Fig. 3 and Table S1, indicate that TOP release is 
faster at pH 5.3 than at pH 7.4. In this case the value of  is 
very similar, ca. 0.5, in both cases, but higher amount of TOP is 
release upon acidification of the medium compared to the 
amount released without acidic stimulus. 
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Fig. 3. “In vial” cumulative TOP release (in percentage) vs time from MSN-FA 
nanosystems when soaked in phosphate buffer solution (PBS) at pH 5.3 and pH 7.4 for 
2 days. 
 
Different hypotheses may be postulated to explain this pH-
responsive drug release behaviour (Fig. S5). The first one relies 
on the degradation of the gelatin in the “in vial” acidic 
conditions. For this purpose, as described in the Materials and 
Methods Section, fluorescent MSNgel, were synthesized. 
Suspensions of fluorescent MSNgel were prepared in PBS at 
the two different pH values of pH 7.4 and pH 5.3 and 
fluorescence of the medium at given time periods was 
measured. The absence of fluorescence signal due to 
fluorescein in both experiments accounts for the lack of 
degradability of the gelatin coating. This is in agreement with 
previous results found in the literature for crosslinked-
gelatine, which does not undergo any appreciable degradation 
in aqueous solution.
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The second hypothesis postulates that when the core-shell 
MSN-gelatin nanosystems are soaked in aqueous media the 
functional groups of gelatin change their ionization state, 
which originates a process of electrostatic repulsions that 
provokes pH-dependent gelatin swelling. It is well-known that 
when polymeric chains have ionisable groups there are 
electrostatic repulsion between such groups, which increases 
the volume of the polymeric chains and also the swelling 
capacity of the polymer coating. The main composition of 
gelatin is polypeptides containing carbonyl, amino and amide 
functional groups that opens the possibility to be positively or 
negatively charged depending on the pH.
42,53 
Therefore, the 
gelatine structure is ionisable because of these equilibria:
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    ‒NH2 + H2O ↔ ‒NH3
+
 + OH
-
 pKb ~ 6.5        (Eq. 2) 
    ‒COOH + H2O ↔ ‒COO
- 
+ H3O
+
 pKa ~ 4.7  (Eq. 3) 
 
In acid medium the present chemical species of the gelatin are 
NH3
+
 and COOH; in basic medium the predominant species are 
NH2 and COO
-
; and in pH’s between 4.0 and 7.0 the existing 
species are anyone of the above-mentioned functional groups, 
i.e., NH3
+
, COO
-
, NH2 or COOH. Thus, in acidic medium, the 
swelling is controlled mainly by the repulsion between NH3
+
 
groups, in basic medium by -COO
-
, and between pH 4.0 and 7.0 
by NH3
+
 and COO
-
. In an attempt to investigate the differences 
in the gelatin swelling degree between pH 5.3 and 7.4, MSNgel 
suspensions into aqueous solutions at these two pH values 
were prepared and the hydrodynamic size of nanoparticles by 
DLS vs. time was recorded. However, no differences in the 
MSNgel diameters were appreciated. This could be ascribed to 
the swelling degree of MSNgel at both pH, which could not be 
detected by DLS due to the broad nanoparticles size 
distributions (Fig. S3).  
 
Fig. 4. TOP species and their relative abundance at pH 5.3 (top) and at pH 7.4 (bottom).  
 
Finally, the host/guest MSN-FA/TOP interactions cannot be 
overruled, since they are the driving forces that govern kinetic 
release profiles from hybrid mesoporous materials.
55
 As 
previously mentioned, it is well-known that the confinement of 
sensitive drugs into mesoporous cavities and appropriate pore 
capping is a widely exploited strategy to avoid cargoes 
degradation. Thus, taking into account that the most abundant 
specie of TOP in its active form is the cationic lactone l-TOP
+ 
(Fig. 4), and knowing that MSN are negatively charged due to 
the silica walls (Fig. S4) the next step was to investigate the 
variations in the surface charge of MSN-FA vs pH. This may 
govern the interaction with the l-TOP
+
 during its diffusion out 
of the nanosystem. -potential values of MSN-FA at pH 5.3 and 
pH 7.4 are respectively ca. -14 and -26 mV, respectively. In 
both cases the negatively charged surface of silica walls may 
interact with the positively charged drug, being responsible of 
slowing down the TOP release from the nanosystems at both 
pH values. However, once the drug diffuses out of the silica 
network it has to pass across the gelatin barrier. Thus, 
ARTICLE Journal Name 
8 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
positively charged drug remains more retained in MSN-FA at 
pH 7.4 than at pH 5.3 because of the greater electrostatic 
attractive interactions with the net negative charge of the 
former. This would really explain the different release profiles 
found for TOP from MSN-FA at the two different pH values. 
For comparative purposes, “in vial” TOP delivery assays where 
carried out from pure-silica MSN at pH 5.3 and pH 7.4 (Fig. 5). 
In this case there is not a protecting barrier that impedes the 
diffusion of the delivery medium inside the mesopores. Thus, 
at pH 5.3 94% of drug is expected to be in the lactone cationic 
form l-TOP
+
, and at pH 7.4 87% of TOP would be in the anionic 
hydrolyzed carboxylate c-TOP- and 15% as zwitterionic c-TOP
±
 
(Fig. 4). Fig. S6 demonstrates that, independently of the pH, 
TOP release in MSN is faster than in MSN-FA, since there is not 
capping layer that slow down the departure of the drug in the 
former. Indeed, contrarily to that occurring in MSN-FA, in this 
case, TOP release from MSN is faster at pH 7.4 than at pH 5.3 
(see Table S1 for the parameters of the kinetic fitting). Thus, 
after 48 of assay 78% and 35% of drug is released from MSN at 
pH 7.4 and pH 5.3, respectively. At both pH values, -potential 
measurements indicate a similar surface charge for MSN of 
around -30 mV (Fig. S4), but the TOP predominant species 
varies. TOP is hydrolyzed to c-TOP
-
 at pH 7.4 results in a 
weaker drug to MSN interaction, hence very fast release is 
achieved. On the contrary, at pH 5.3 TOP preserves its active 
cationic lactone form l-TOP
+
 capable to undergo electrostatic 
attractive interactions with the negatively charged MSN silica 
walls.  
 
Fig. 5. “In vial” cumulative TOP release profiles (in percentage) versus time from MSN 
nanosystems when soaked in phosphate buffer solution (PBS) at pH 5.3 and pH 7.4 for 
2 days. 
3.3. In vitro behaviour of the nanosystems 
Once MSN-FA nanosystem was fully characterized and its pH-
sensitive TOP release capability was evaluated “in vial”, the 
next step was to study its in vitro behaviour as selective carrier 
for targeted TOP delivery. For this purpose, we cultured 
MSNgel and MSN-FA nanosystems in presence of two types of 
cells populations: MC3T3-E1 and LNCaP cells. LNCaP is a 
human prostate cancer cell line that overexpresses folate 
binding proteins (FBP), with high affinity towards FA,
41 and 
MC3T3-E1 is a preosteoblastic cell line that, as normal cell, 
minimally expresses membrane surface markers with affinity 
towards FA.
56,57
  
The in vitro cytotoxicity study was determined by the 
exposition of MC3T3-E1 and LNCaP cells to different amounts 
of nanoparticles (20, 50 and 100 µg/mL). It was observed that 
none of the studied materials, neither MSNgel (Fig. 6a) nor 
MSN-FA (data not shown), induced significant cytotoxicity 
measured by a MTS assay (cell viability was in all cases > 99% 
that of the control) or affected to the morphology in both type 
of cells, as observed by fluorescence microscopy (Fig. S6). 
 
 
Fig. 6. (a) Cell viability in contact with different concentrations of nanoparticles. Similar 
proliferation results were obtained in contact with MSN-FA. (b) Cellular uptake in the 
presence of MSNgel and MSN-FA at 2 hours, measured by flow cytometry. (c) 
Fluorescence confocal laser scanning microscopy images of MC3T3-E1 and LNCaP cells 
incubated with MSNgel and MSN-FA at 2 hours of cell culture. *p<0.05 vs 
corresponding MSNgel control; **p<0.05 vs. corresponding control without 
nanoparticles #p<0.05 vs. corresponding control and same condition in MC3T3-E1 cells 
(Student´s t-test).  
Cellular uptake and internalization of the nanosystems were 
observable by flow cytometry and confocal microscopy in 
MC3T3-E1 and LNCaP cells in contact with the different 
nanoparticles (100 µg/mL) for 2 hours (Fig. 6b). After 2 hours, 
MSN-FA internalization in LNCaP increases and it is always 
higher compared with the internalization degree within 
MC3T1-E1 preosteoblastic cells. However slightly 
internalization of MSN-FA is also observed in MC3T3-E1 
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because these cells also exhibit folate surface markers at the 
cell membrane, although are not overexpressed. Flow 
cytometry results give away that MSN-FA are internalized 
through a FBP mediated mechanism within tumour cell line 
LNCaP.  
The cellular uptake results obtained by flow cytometry were 
also confirmed by confocal microscopy using fluorescein 
labeled nanoparticles (Fig. 6c). No fluorescence was observed 
in the end slices corresponding to the external cellular 
surfaces, suggesting that the nanoparticles did not adsorb on 
the cell membranes. Therefore, the modifications presents in 
the MSN-FA nanoparticles (100 g/mL) improve the cellular 
uptake (in a very short time, 60 min) compared to MSNgel in 
both type of cells but especially in LNCaP cells. These results 
are in concordance with the overexpression of FBP in these 
tumor cells and the higher affinity by MSN-FA nanoparticles.
 
This higher affinity for cancer cells overexpressing FBP made 
MSN-FA promising drug nanocarriers to be targeted to this 
type of tumour cells. 
  
 
Fig. 7. Cell viability in contact with different concentrations of TOP (2.5 and 10 µg/mL) 
loaded or not into MSN-FA at a) 24, b) 48 and c) 72 hours of cell culture. *p<0.05 vs 
TOP not loaded into MSN-FA (Student´s t-test).  
In addition, we performed an in vitro cytotoxicity study with 
TOP concentrations (2.5 and 10 µg/mL) loaded or not in MSN-
FA nanoparticles in presence of MC3T3-E1 or LNCaP cells at 
different times (24, 48 and 72h, Fig. 7 a-c). It was observed 
that any concentration of TOP, loaded or not in MSN-FA 
nanoparticles, induced significant cytotoxicity at 24 or 48 
hours (Fig. 7 a,b). Furthermore, TOP loaded or not in MSN-FA 
failed to affect MC3T3-E1 cell viability too at 72h and only TOP 
(10 µg/mL) loaded in MSN-FA nanoparticles significantly 
decreased the cell viability in tumour LNCaP cells at this time 
(Fig. 7c). These findings suggest that the decrease in LNCaP 
viability at 72h, and not before, can be due to the slow release 
of TOP loaded into the MSN-FA nanoparticles that was 
previously demonstrated (Fig. 3). On the other hand, we 
observed this effect only in LNCaP cells because, as previously 
commented, LNCaP overexpresses FBP with high affinity 
towards FA, and MC3T3-E1 does not. In addition, these results 
are in concordance with the observed higher internalization 
degree of MSN-FA nanoparticles in LNCaP cells (Fig. 6b). 
3. Conclusions 
In conclusion, an innovative nanosystem able to selectively 
deliver TOP to tumor cells has been developed. MSNs has been 
employed as nanocarriers and a gelatin shell has been used as 
multifunctional coating able to prevent TOP departure and 
therefore protecting it from inactivation by hydrolysis at the 
physiological pH of 7.4, which constitutes one of the major 
issues in the clinical application of this drug. In addition, 
biopolymer coating governs pH-dependent TOP kinetics and 
provides multiple anchorage points for the grafting of 
targeting ligands, which promote selectivity towards cancer 
cells overexpressing surface markers with affinity towards such 
ligands. In vitro assays demonstrated that these targeted 
nanosystems selectively killed tumor cells, whereas free TOP 
failed to affect viability of both tumor and cell lines. This novel 
nanosystem constitutes a significant advance towards the 
development of a library of nanomedicines for antitumor 
therapy.  
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